Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity Statement

v3.22.1
Condensed Consolidated Statements of Stockholders' Equity Statement - USD ($)
Total
Series A common stock
Series B common stock
Series C common stock
Series F common stock
Preferred Stock
Common Stock
Series A common stock
Common Stock
Series B common stock
Common Stock
Series C common stock
Common Stock
Series F common stock
Additional Paid-in Capital
Accumulated Deficit
Preferred stock, shares outstanding, beginning of period at Dec. 31, 2020           0            
Common stock, shares outstanding, beginning of period at Dec. 31, 2020             0 0 0 0    
Stockholders' Equity, beginning of period at Dec. 31, 2020           $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Issuance of common stock, shares                   11,500,000    
Issuance of common stock                   $ 1,150 24,137  
Net earnings (loss) $ (44,295)                     (44,295)
Preferred stock, shares outstanding, end of period at Mar. 31, 2021           0            
Common stock, shares outstanding, end of period at Mar. 31, 2021             0 0 0 11,500,000    
Stockholders' Equity, end of period at Mar. 31, 2021 $ (19,008)         $ 0 $ 0 $ 0 $ 0 $ 1,150 24,137 (44,295)
Preferred stock, shares outstanding, beginning of period at Dec. 31, 2021 0         0            
Common stock, shares outstanding, beginning of period at Dec. 31, 2021   1,090,000 0 0 8,625,000   1,090,000 0 0 8,625,000    
Stockholders' Equity, beginning of period at Dec. 31, 2021 $ (18,322,501)         $ 0 $ 109 $ 0 $ 0 $ 863 0 (18,323,473)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Issuance of common stock, shares                   0    
Issuance of common stock                   $ 0 0  
Net earnings (loss) $ 2,972,316                     2,972,316
Preferred stock, shares outstanding, end of period at Mar. 31, 2022 0         0            
Common stock, shares outstanding, end of period at Mar. 31, 2022   1,090,000 0 0 8,625,000   1,090,000 0 0 8,625,000    
Stockholders' Equity, end of period at Mar. 31, 2022 $ (15,350,185)         $ 0 $ 109 $ 0 $ 0 $ 863 $ 0 $ (15,351,157)